| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5172969
Max Phase: Preclinical
Molecular Formula: C17H19FN4O5S
Molecular Weight: 410.43
Associated Items:
Representations
Canonical SMILES: CCCn1c(=O)c2[nH]c(-c3cccc(OS(=O)(=O)F)c3)nc2n(CCC)c1=O
Standard InChI: InChI=1S/C17H19FN4O5S/c1-3-8-21-15-13(16(23)22(9-4-2)17(21)24)19-14(20-15)11-6-5-7-12(10-11)27-28(18,25)26/h5-7,10H,3-4,8-9H2,1-2H3,(H,19,20)
Standard InChI Key: RMEHELNLDXUWDI-UHFFFAOYSA-N
Associated Targets(Human)
Adenosine A2b receptor 7672 Activities
Adenosine A2a receptor 16305 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Adenosine A1 receptor 17603 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Adenosine A3 receptor 15931 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 410.43 | Molecular Weight (Monoisotopic): 410.1060 | AlogP: 1.97 | #Rotatable Bonds: 7 |
| Polar Surface Area: 116.05 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 7.08 | CX Basic pKa: | CX LogP: 2.71 | CX LogD: 2.32 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.60 | Np Likeness Score: -1.01 |
References
| 1. Beerkens BLH, Wang X, Avgeropoulou M, Adistia LN, van Veldhoven JPD, Jespers W, Liu R, Heitman LH, IJzerman AP, van der Es D.. (2022) Development of subtype-selective covalent ligands for the adenosine A2B receptor by tuning the reactive group., 13 (7.0): [PMID:35923720] [10.1039/d2md00132b] |
Source
Source(1):